From pig kidney transplants to the development of a new schizophrenia drug, here are five of the biggest medical ...

Evenamide is under clinical development by Newron Pharmaceuticals and currently in Phase III for Schizophrenia.

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

Iloperidone LAI is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Schizophrenia.

In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug ...

schizophrenia treatment market is expected to expand globally by enhancing existing treatments and improving patient care.

Hi, it’s Bob in New York. An FDA safety program is preventing sick patients from getting the world’s most effective ...

While outlook for schizophrenia management made headway, opportunities remain to improve patient outcomes.Dublin, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The "Schizophrenia: Seven-Market Drug Forecast ...

Schizophrenia, a complex mental health condition that affects how a person thinks, feels, and behaves, requires a ...

The data analytics and consulting company valued the market at $8.4 billion in 2021. The forecasted 7.4% compound annual ...

“Children with this genetic hearing loss…the only treatment option for them until ... 1st new class of schizophrenia drug in more than 3 decades In September, the FDA approved the first ...